This bill amends several chapters of the General Laws to mandate coverage for epinephrine injectors across various insurance policies and health plans. Specifically, it introduces new sections in Chapters 32A, 118E, 175, 176A, 176B, and 176G, which require that any insurance coverage provided to active or retired employees, Medicaid recipients, and individuals under various health plans must include coverage for the appropriate weight-based dosage of epinephrine injectors. The bill ensures that these injectors will not be subject to higher deductibles, coinsurance, copayments, or out-of-pocket limits than other prescribed drugs.

The definition of "epinephrine injector" is standardized across the bill, referring to both auto-injectors and pre-filled syringes approved by the FDA for administering epinephrine. This comprehensive approach aims to enhance access to life-saving medication for individuals at risk of severe allergic reactions, ensuring that financial barriers do not impede their ability to obtain necessary treatment.